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Abstract
Peptidoglycan hydrolases are a double-edged sword. They are required for normal cell division, but when dysregulated can
become autolysins lethal to bacteria. How bacteria ensure that peptidoglycan hydrolases function only in the correct spatial
and temporal context remains largely unknown. Here, we demonstrate that dysregulation converts the essential
mycobacterial peptidoglycan hydrolase RipA to an autolysin that compromises cellular structural integrity. We find that
mycobacteria control RipA activity through two interconnected levels of regulation in vivo—protein interactions coordinate
PG hydrolysis, while proteolysis is necessary for RipA enzymatic activity. Dysregulation of RipA protein complexes by
treatment with a peptidoglycan synthase inhibitor leads to excessive RipA activity and impairment of correct morphology.
Furthermore, expression of a RipA dominant negative mutant or of differentially processed RipA homologues reveals that
RipA is produced as a zymogen, requiring proteolytic processing for activity. The amount of RipA processing differs
between fast-growing and slow-growing mycobacteria and correlates with the requirement for peptidoglycan hydrolase
activity in these species. Together, the complex picture of RipA regulation is a part of a growing paradigm for careful control
of cell wall hydrolysis by bacteria during growth, and may represent a novel target for chemotherapy development.
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Introduction
Mycobacterium tuberculosis is the causative agent of tuberculosis
and accounts for up to 10 million symptomatic infections a year
[1]. The spread of multi-, extensively- and now totally- drug
resistant strains [2] has created a pressing need to understand
essential mycobacterial processes in an effort to define novel
targets for chemotherapy. One highly essential bacterial process is
peptidoglycan (PG) synthesis and remodeling, which is critical for
providing structural integrity in nearly all bacteria. PG forms a
continuous macromolecular mesh that is part of the bacterial cell
wall and is required for correct cellular morphology and
opposition to osmotic forces. Despite extensive biochemical and
genetic characterization of the enzymes responsible for the
synthesis and degradation of PG (reviewed in [3,4]), the
mechanism by which these enzymes coordinate their activities
remains poorly defined. It is clear, however, that dysregulation of
this homeostatic balance frequently has lethal effects on the
bacterium—inactivation of peptidoglycan synthases, either
through the use of penicillin derivatives or overexpression of
dominant negative forms of PG synthetic enzymes, induces lysis of
cells [5,6]. In many cases, this lethality can be suppressed by
inactivation of several peptidoglycan hydrolases [5,7], suggesting
that PG hydrolase autolysin activity is restrained by functional
interactions with PG synthases. This idea is consistent with a
‘make-then-break’ approach to cell wall synthesis where new PG
subunits are first incorporated before the existing sacculus is
cleaved to allow expansion [8]. One example of this is the
formation of the septal PG—cells ensure that the septal PG is
formed before PG hydrolases cleave apart the daughter cells.
Recent work suggests that the activity of PG synthetic and
hydrolytic enzymes is regulated by the formation of protein
complexes. In E. coli, the PG amidases AmiA, AmiB and AmiC
can interact with non-enzymatic partners that upregulate septal
peptidoglycan hydrolysis [9]. Conversely, the major bifunctional
PG synthases, PBP1A and PBP1B in E. coli interact with and rely
on essential lipoprotein partners for function [10]. In addition to
interactions with non-enzymatic partners, several affinity chro-
matography and genetic studies have identified interactions
between PG modulating enzymes themselves [11]. While the
exact interactions may be species-specific, in general, PG
synthases can associate with both other PG synthases and with
PG hydrolases. Likewise, PG hydrolases can form predicted
hydrolytic complexes with other autolysins [11–13]. These results
PLOS Pathogens | www.plospathogens.org 1 February 2013 | Volume 9 | Issue 2 | e1003197suggest a general paradigm where PG modulating enzymes of
both similar and opposing functions assemble as multi-protein
complexes that spatially and temporally coordinate PG synthesis
and hydrolysis during bacterial growth and division. An
immediate challenge is to translate the many identified interac-
tions into functional in vivo effects on the growth and division of
bacteria.
Previously, we have studied regulation of the essential M.
tuberculosis PG hydrolase, RipA (Rv1477). RipA belongs to the
NLPC/p60 family, and has been characterized as a D,L D-
glutamate-diaminopimelic acid (DAP) endopeptidase that cleaves
within the pentapeptide bridges of the PG sacculus, thereby
removing cell wall crosslinks [14]. The RipA homologue in
Listeria (P60) and in Mycobacterium marinum (IipA) can be deleted,
but this causes septal resolution defects [15,16]. In contrast, RipA
is essential in M. tuberculosis [17], and depletion of RipA produces a
chaining phenotype in M. smegmatis, which causes severe growth
inhibition [18]. This is unlike the case in E. coli, where extensive
chaining and growth inhibition requires inactivation of several PG
hydrolases [19].
In this work, we interrogate the mechanism by which RipA
activity is regulated in vivo during vegetative growth. We report
that RipA requires careful control to support growth and division
without compromising the cell’s structural integrity—RipA
becomes a lethal autolysin when its activity is dysregulated.
Under physiological conditions, RipA relies on protein interac-
tions to correctly control its degradative capacity. These
interactions are also necessary for proteolytic cleavage of RipA
to produce active enzyme. RipA cleavage and activation is more
robust in M. smegmatis than in the pathogenic M. tuberculosis or M.
bovis BCG, which may be a reflection of the different PG
hydrolysis requirements between fast and slow growing myco-
bacteria. However, bypassing RipA cleavage by overexpressing
fully active truncated enzyme compromises the structural
integrity of both M. smegmatis and M. tuberculosis, suggesting that
RipA cleavage may be rate-limited in order to synchronize PG
hydrolysis with the growth rate of the bacterium. These results
suggest a model in which RipA is regulated by several
interconnected post-transcriptional mechanisms—proteolytic
processing produces active enzyme, while protein-protein inter-
actions upstream and downstream of cleavage ensure RipA
functions correctly at the septum.
Results
Dysregulated RipA functions as a lethal autolysin
When RipA is depleted, daughter cells are unable to separate
and instead, grow as chains (Figure 1A). While cells require
peptidoglycan hydrolysis to accomplish cell separation, excessive
cell wall degradation can compromise structural integrity and lead
to lysis. We hypothesized that RipA sits in this precarious situation,
where the cell cannot tolerate either too little or too much RipA
activity.
We investigated whether excessive RipA activity is toxic to
mycobacteria by inducing M. smegmatis RipA (RipASm) from a
tetracycline-inducible episomal plasmid in M. smegmatis. Unlike the
chaining phenotype we have previously observed with RipA
depletion, RipA overexpression caused the rod-shaped cells to
become spherical and lyse, (Figure 1A, 1D (time-lapse movie in
Video S1). This is dependent on catalytic activity, as overexpres-
sion of a catalytic mutant, RipASm C408A, does not display this
phenotype (Figure 1A, 1D, (time-lapse movie in Video S2). The
spherical phenotype of RipASm overexpression led to a severe
growth defect by optical density (Figure 1B) and over one hundred
fold killing, as determined by CFU enumeration (Figure 1C).
Thus, excessive RipA activity in the cell is highly lethal.
RipA depletion protects against PBP inhibition
To determine whether a more physiological level of RipA could
be converted to a lethal autolysin, we dysregulated RipA activity
through the use of the beta-lactam antibiotic meropenem. Beta-
lactam antibiotics block PG precursor incorporation, which causes
excessive PG hydrolase activity and cell lysis [7]. While M.
tuberculosis is relatively resistant to most beta-lactams, recent work
has shown that meropenem is more resistant to the endogenous
mycobaterial beta-lactamase, and is highly effective at killing M.
tuberculosis, especially in combination with the beta-lactamase
inhibitor clavulanate [20]. Meropenem targets PBP2 and PBP3 in
E. coli, as well as L,D transpeptidases in M. tuberculosis [21,22].
Since RipA is known to interact with the PG synthase PBP1,
which is required for normal vegetative growth [23] and
morphology in mycobacteria [24] (depletion of the protein leads
to rounded cells), we asked whether meropenem treatment can
dysregulate RipA and convert the enzyme into a lethal autolysin.
We first treated M. smegmatis with 10 mg/mL meropenem and
assessed morphological changes over time by microscopy. Treated
cells filament and swell at the poles and septa, which are the sites
of mycobacterial PG incorporation (Figure 2A, arrows). This
morphological toxicity correlated with a decrease in optical density
over time, which suggested lysis (Figure 2B). This was borne out by
CFU analysis, which showed that 80% of treated cells were killed
within 6 hours of meropenem treatment (Figure 2C, bar 2).
The bulging at sites of PG incorporation after meropenem
treatment suggested an excess of PG hydrolase activity. Since
RipA localizes both to poles and septa, we hypothesized that RipA
may play a role in killing meropenem treated cells. To test this
idea, we depleted M. smegmatis of RipA before meropenem
treatment (Figure S1A) and then assessed survival with merope-
nem treatment by CFU enumeration. We found that unlike RipA
replete cells (Figure 2C, bar 2), meropenem did not kill RipA
depleted cells (Figure 2C, bar 4). Furthermore, while RipA replete
cells bulged under meropenem treatment as expected (Figure 2D,
arrows), the RipA depleted cells appeared refractory to swelling
(Figure 2D). As a control, cells were treated with SDS (which
causes non-specific cell wall and membrane stress), as well as
streptomycin, which targets protein synthesis. These control cells
showed no survival (Figure S1B) or morphological (Figure S2)
Author Summary
Peptidoglycan (PG) is a major component of the bacterial
cell wall, which forms a flexible, but strong mesh around
the cell to oppose osmotic pressure and prevent lysis. PG is
also dynamically modified, continually being disassembled
and polymerized as the cell elongates and divides. It
remains poorly understood how cells can titrate enough
hydrolysis of the PG to allow bacterial growth without
leading to excessive digestion and disruption of cellular
integrity. In our work, we have identified two methods by
which a critical PG hydrolase, RipA, is carefully controlled in
Mycobacterium tuberculosis—protein interactions help
prevent lethal RipA dysregulation, while proteolytic cleav-
age is used as a second step to activate the enzyme in
order to separate daughter cells. Our work elaborates
multiple post-transcriptional mechanisms for preventing
PG hydrolases from becoming lethal autolysins. These
different levels of regulation may serve as a more general
paradigm for PG remodeling in other bacterial species.
RipA Regulation Requires Proteolysis
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ing RipA specifically interacts with meropenem-affected pathways.
Given that RipA enzymatic activity is modulated through protein-
protein interactions with different PG synthetic and hydrolytic
partners [18,24], the meropenem data suggest that RipA is held in
check in complexes by an interacting protein, such as PBP1.
Furthermore, although there are many hydrolases that could
contribute to cell death when PG synthesis is blocked, we found
that at least for the synthases blocked by the clinically relevant
beta-lactam antibiotic meropenem, RipA is quantitatively the
single most important hydrolase.
RipA post-transcriptional processes are required for
septal resolution
Our results demonstrate that RipA dysregulation is highly
detrimental to the cell. Thus, mycobacteria must control the
activity of RipA during growth—there must be enough PG
hydrolase activity around to support growth and division, but not
an excessive amount so as to compromise structural integrity. One
way this control may be regulated is at the transcriptional level.
We assessed whether the cell downregulates RipA expression
using quantitative PCR. Since RipA is required for septation,
which does not occur in non-replicative conditions, we compared
RipA expression between exponential and stationary phases. We
found that RipA remained expressed from exponential phase
through the transition into stationary phase (Figure S3), suggesting
there may be post-transcriptional mechanisms responsible for
restraining RipA activity when it is not needed. Thus, we
investigated whether achieving tight control of RipA activity
may rely on post-transcriptional processes.
We hypothesized that removal of wildtype RipA from its
endogenous niche in vivo would inhibit correct septal resolution
and therefore phenocopy RipA depletion. If RipA requires
downstream interactions for activity, e.g. with members of septal
complexes or with post-translational enzymatic regulatory pro-
teins, then we should be able to create a dominant negative RipA
mutant, where the critical catalytic cysteine [25] is mutated to a
nonfunctional alanine. Overexpression of the RipASm C408A
catalytic mutant should result in competition between nonfunc-
tional RipA and endogenous RipA for required post-translational
activation processes. If RipA requires these interactions to
function, then we would observe chaining. Indeed, when we
induced RipASm C408A, cells grew as short chains (Figure 1A,
white arrows), suggesting that RipA interactions are necessary for
correct septal PG hydrolysis.
While overexpression of the RipASm C408A mutant produced a
severe growth defect (Figure 1B, 1C), it was not accompanied by
the widespread lysis that was observed upon wildtype RipASm
overexpression (Figure 1C). The apparent drop in optical density
upon longer induction of the RipASm C408A strain (Figure 1B)
was due to clumping of the culture, which though affecting optical
density, did not lead to a drop in CFU, indicating growth
inhibition rather than lysis (Figure 1C). However, we did observe
occasional lysis of the RipASm C408A strain in addition to the
dominant negative chaining phenotype. Some cells within a chain
produced a slight bulging phenotype, which is indicative of an
increase in PG hydrolytic activity (Figure 1A, red arrows). These
bulging cells, like in RipA dysregulated cells, can go on to lyse
(Figure 1D, Video S2), though this does not lead to detectable cell
death by CFU enumeration (Figure 1C). It is possible that
displacement of endogenous wildtype RipA from complexes at the
septum leads to activity at ectopic sites in a subset of cells.
Alternatively, RipA overexpression could stimulate other endog-
enous PG hydrolases.
RipA is proteolytically processed in vivo
When we used a RipA polyclonal antibody that recognizes a C-
terminal epitope, we observed truncated RipA species from
mycobacteria by Western blotting. When we overexpressed
RipASm, we found several bands smaller than the predicted full
length protein (Figure 3A, lane 3). Likewise, we saw these
truncated bands when we overexpressed RipASm C408A in M.
smegmatis (Figure 3A, brackets). These products were not due to
non-specific cytoplasmic degradation of overexpressed RipA, as
we fractionated RipASm C408A overexpressing cells and found
that RipA processed species were enriched in the cell wall fraction
(Figure S4A). The efficiency of fractionating mycobacteria was
confirmed by Western blotting against RpoB (cytosolic) and
mycobacterial antigen 85 (cell wall) markers (Figures S4B, S4C).
Thus, these results suggest that RipA undergoes physiological post-
translational processing in the periplasmic or cell wall compart-
ment.
To further demonstrate that RipA processing is physiological
and not an artifact of overexpression, we used Western blotting to
estimate the size of RipA in wildtype M. smegmatis whole cell
lysates. In mid-exponential phase cells, RipA formed a smear of
,30 kDa (Figure 3A, lane 2, red arrow) with no detectable full
length protein present. This signal was specific for RipA, as cells
depleted for RipA (Figure 3A, lane 1) had decreased signal
compared to wildtype cells (Figure 3A, lane 2) when equal
amounts of total protein were analyzed (Figure 3B). Furthermore,
processed endogenous RipA partitioned to the cell wall compart-
ment (Figure S4A). The smear of processed RipA suggests there
are multiple processing sites. This may represent multiple cleavage
products or further modifications to the protein. A recent crystal
structure of RipA suggests a protease labile loop exists between the
N inhibitory and C terminal PG hydrolase domains; this loop is
hypothesized to be the site of cleavage in vitro, which is required for
RipA enzymatic activation [25]. We mutated candidate residues in
the loop in an attempt to identify cleavage sites but were
unsuccessful in blocking RipA processing (Figure S5).
Truncated RipA species were found associated with the cell wall
compartment and in culture filtrates. In the culture filtrate, a RipA
fragment appeared as a single band at approximately 25 kDa
Figure 1. Dysregulation of RipA in M. smegmatis causes growth attenuation. (A) Micrographs of RipA dysregulated strains after 24 hours of
depletion or induction. RipA depletion was achieved by placing ripA under the control of an anhydrotetracycline (aTc) inducible promoter [18].
Depletion occurred over 24 hours by growing this strain in the absence of aTc. Alternately, wildtype RipA (RipASm) or catalytically inactive (RipASm
C408A) M. smegmatis RipA was overexpressed in wildtype cells. In the C408A overexpression strain, both chaining (white arrows) and bulging (red
arrows) cells were observed. Membranes were stained with TMA-DPH. Scale bar represents 2 mm. (B) M. smegmatis strains overexpressing wildtype
(RipASm) and catalytically inactive (C408A) RipA were induced with aTc and growth assessed by OD600 over time. (C) M. smegmatis was induced with
aTc to overexpress either wildtype RipASm or inactive RipASm C408A. Colony forming units (CFUs) were enumerated at the indicated time course by
serial dilution and plating onto inducer-free agar. (D) Time-lapse microscopy was used to visualize M. smegmatis grown on an agar pad with aTc to
overexpress wildtype RipASm (left panels) or catalytically inactive RipASm C408A (right panels). A GFP reporter was used to visualize RipA induction as
well as determine cytokinesis and cell lysis. Presented here are frames from agar pads at four time points post-induction, showing individual cells
before and after cell lysis, as detected by loss of GFP signal (arrows). Scale bar represents 2 mm.
doi:10.1371/journal.ppat.1003197.g001
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PLOS Pathogens | www.plospathogens.org 4 February 2013 | Volume 9 | Issue 2 | e1003197Figure 2. RipA depletion protects cells from meropenem-induced lysis. (A) A RipA conditional depletion strain of M. smegmatis was grown
in the presence of inducer (RipA replete conditions) and 10 mg/mL of meropenem. Cells were imaged for morphological changes at various time
points after meropenem addition. During meropenem treatment, septal and polar bulging were observed (arrows). Cell membranes were stained
with FM4-64. Scale bar represents 2 mm. (B) Lysis of M. smegmatis cells from (A) was also characterized by OD600 at various times post meropenem
treatment. (C) The RipA conditional depletion strain of M. smegmatis was grown with anhydrotetracylcine (aTc) inducer (RipA replete) or pre-depleted
RipA Regulation Requires Proteolysis
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C-terminally tagging endogenous RipA on the chromosome of M.
smegmatis with a FLAG epitope. This 25 kDa species exhibited
altered mobility due to the epitope and could be detected by both
anti-RipA (Figure 3C, left panel) and anti-FLAG antibodies
(Figure 3C, right panels). These results indicate that RipA exists
physiologically in a smaller form than the predicted full length
protein.
RipA requires processing for activity
The observation of RipA cleavage suggested this process could
be required for the protein’s function in vivo. To test whether RipA
processing is correlated with division, we titrated overexpression of
RipASm C408A and quantified the amount of induction needed to
mediate chaining. We found that low level overexpression with
30 ng/mL inducer was sufficient to cause chaining (Figure 4A)
without saturating the processing machinery, since these cells did
not accumulate full length RipA (Figure 4B). Instead, mildly
overexpressed RipA was processed down to two sets of smaller
species at around 23 kDa and 12 kDa (Figure 4B). We also saw a
dose-dependent saturation of the endogenous processing capacity,
with high induction leading to accumulation of full length RipA
(Figure 4B), as well as loss of processed endogenous RipA (Figure
S6A). When we quantified recombinant protein levels by
comparing densitometry with endogenous RipA protein
(Figure 4C), we found that even mild RipASm C408A overexpres-
sion at 30 ng/mL of inducer (processed recombinant protein is
approximately 10% of endogenous wild type RipA levels) was
sufficient to cause chaining and cellular toxicity (Figure 4A).
Together with qPCR data showing that RipASm C408A induction
does not affect endogenous RipA transcription (Figure S6B), these
data suggest direct competition between the RipAsm C408A
mutant and endogenous RipA for processing machinery, and that
the processed, not full length, form of RipA is required for division.
However, though correlated with function, the processed species
we observed could be the product of an inactivating event. To test
this, we took advantage of the observation that the M. tuberculosis
homologue of RipA (RipATB) functions differently in M. smegmatis
than its native counterpart, despite having the same general
domain architecture (Figure S7). In contrast to RipASm, which is
(RipA deplete) in the absence of aTc for 6 hours. These cells were then treated with 10 mg/mL of meropenem for 6 hours, washed, serially diluted and
plated for CFU enumeration. (**, the difference between survival in RipA replete cells and RipA depleted cells in the presence of meropenem was
significant with a p-value=0.0006). (D) Cells post meropenem treatment in (C) were imaged by fluorescence microscopy to determine morphological
changes. The plasma membrane was visualized with FM4-64. Scale bar represents 2 mm.
doi:10.1371/journal.ppat.1003197.g002
Figure 3. RipASm but not RipATB is proteolytically processed in M. smegmatis. (A) Whole cell lysates were made from cells depleted for RipA
(Depl), wildtype M. smegmatis (WT), and cells overexpressing either wildtype RipASm (RipASm), RipATB (RipATB), or catalytically inactive RipASm C408A
(C408A). The lysates were probed with anti-RipA polyclonal antibody. Full length RipA (arrow), and proteolytically cleaved endogenous RipA (red
arrow) and recombinant species (brackets) were detected. (B) Coomassie stain of RipA-expressing M. smegmatis cells showing total protein loaded.
Lanes are identical to (A). As RipASm C408A induction is particularly strong, this sample was deliberately underloaded to prevent its signal in (A) from
overwhelming detection of less abundant species. (C) Western blots with anti-RipA (left panel) and anti-FLAG antibodies (right panel). Culture filtrates
were collected from wildtype M. smegmatis (WT) and cells in which chromosomal RipA was C-terminally fused to a FLAG epitope (FL). A truncated
RipA species that is shifted by the FLAG tag was observed (asterisk).
doi:10.1371/journal.ppat.1003197.g003
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PLOS Pathogens | www.plospathogens.org 6 February 2013 | Volume 9 | Issue 2 | e1003197Figure 4. Proteolyzied RipASm C408A overexpression correlates with morphological toxicity. (A) Micrographs of M. smegmatis grown in
various concentrations of inducer to overexpress RipASm C408A-FLAG. Scale bar represents 2 mm. (B) Total cell lysates from M. smegmatis
overexpressing RIpASm C408A-FLAG under various inducer concentrations were probed with anti-FLAG antibody. Both full length (arrow) and
processed RipASm C408A species (brackets) were detected, including two major processed species: a band at 25 kDa and a doublet around 12 kDa.
(C) Samples from (B) were probed with anti-RipA antibody (Figure S7) and densitometry analysis performed. The levels of full length (black),
processed (red) and total (blue) recombinant RipASm C408A proteins were compared to endogenous RipA levels. The fold overexpression of RipASm
C408A relative to endogenous RipA was graphed as a function of inducer concentration.
doi:10.1371/journal.ppat.1003197.g004
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smegmatis, surprisingly caused no toxicity or cell morphological
differences (Figure 5A,B), despite similar protein levels (Figure 3A).
We examined whether RipASm toxicity was correlated with its
processing by performing Western blot analysis on RipATB
overexpressing M. smegmatis. In contrast to overexpression of
RipASm, when wildtype RipATB is overexpressed we observed only
a single full length band at 55 kDa (Figure 3A, right arrow). The
absence of processing correlates with the lack of detectable RipATB
toxicity in M. smegmatis. Thus, we hypothesize that proteolytic
cleavage is required for activating RipA in vivo.
However, it could be formally possible that RipATB cannot
recognize M. smegmatis peptidoglycan or is not intrinsically active
enough in M. smegmatis to cause morphological defects. To test if
RipATB can be enzymatically functional in M. smegmatis,w e
deleted the predicted N-terminal inhibitory segment by fusing the
truncated active domain of RipATB to the RipA secretion signal
peptide (RipATB-AD). As a control, we also produced a construct
in which the M. smegmatis RipA active domain (RipASm-AD) can
be secreted. None of the strains produced growth defects when
uninduced (Figure S8). As expected, RipASm-AD like full length
RipASm, was fully functional when induced and disrupted cell wall
integrity, leading to bulging of the cells and a concomitant growth
defect (Figure 6A,B). When RipATB-AD was secreted, we found
that it was also functional and behaved in the same way as
RipASm-AD (Figure 6A,B). Thus, the catalytic domain of RipATB
can be active in M. smegmatis, but full length RipATB is not toxic
because it does not undergo efficient processing in M. smegmatis.
RipA processing in M. tuberculosis requires additional
steps
Given the potentially toxic nature of hyperactive RipA we
hypothesized that RipA processing and activation may be less
robust in slow-growing mycobacteria in order to match their much
slower rate of growth and consequent lower requirement for
peptidoglycan hydrolysis. To investigate this model, we first
determined whether RipA is processed in M. tuberculosis by
overexpressing RipATB. By Western blot analysis, we found
multiple immunoreactive smaller species of RipATB, suggesting
processing in M. tuberculosis (Figure 7D, brackets). However, the
induction of RipATB in M. tuberculosis did not produce morpholog-
ical changes or growth defects, even after five days of induction
(Figure 7A,B). This overexpression produced about 3 fold more
protein (most of which is in the processed form) than endogenous
full length RipA (Figure 7E), which is similar to the amount of
overexpression needed to observe cell chaining in M. smegmatis with
the RipASm C408A allele (Figure 4C). The lack of morphological
changes in M. tuberculosis is also in contrast with the marked lethality
of RipASm overexpression in M. smegmatis (Figure 1).
One explanation for this dichotomy may be that the slow
growth of M. tuberculosis might mask morphological or growth
defects caused by RipA overexpression. To test this possibility, we
bypassed RipA processing by secreting truncated RipATB-AD in
M. tuberculosis. Induction of RipATB-AD produced a severe growth
defect in M. tuberculosis (Figure 7C), and concomitant cell rounding
(Figure 7A) similar to that seen when RipASm was overexpressed in
M. smegmatis. These results show that unchecked RipA activity is
toxic even to slow-growing mycobacteria. Since full length RipATB
induction does not produce this toxicity, M. tuberculosis may have
intrinsically less robust RipA processing than in M. smegmatis.
Indeed, in M. tuberculosis, we observed a band of 55 kDa on
Western blots probed with anti-RipA antisera. This band is the
same size as full length RipATB and appears in both uninduced
and induced samples (Figure 7D, arrow). As this form was not
detected in wildtype M. smegmatis lysates (Figure 3A), it may
represent endogenous, unprocessed full length RipA. The same
Figure 5. RipA is differentially active in a species-specific manner. (A) Fluorescence micrographs of M. smegmatis strains induced with aTc to
overexpress M. tuberculosis RipA (RipATB)o rM. smegmatis RipA (RipASm). Membranes were stained with TMA-DPH. Scale bar represents 2 mm. (B) M.
smegmatis strains in (A) were induced with aTc to overexpress RipATB and RipASm constructs. Growth of these strains was monitored over time by
OD600.
doi:10.1371/journal.ppat.1003197.g005
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(Figure S9). These data, along with the active domain overex-
pression analysis, support the idea that slow-growing mycobacteria
process RipA less efficiently in order to keep this potentially lethal
activity in check.
Discussion
Bacteria rely on peptidoglycan (PG) for shape and structure.
The prevailing view of PG remodeling requires the concerted
action of synthetic enzymes ligating new subunits into the existing
PG lattice followed by hydrolysis of the PG sacculus by autolysins
to allow cellular expansion or division. This process is accom-
plished through the action of large holoenzyme complexes in the
periplasm consisting of both PG synthetic and hydrolytic
enzymes. Disruption of PG synthesis in these complexes can
dysregulate cognate PG hydrolases, which can then become
autolysins that lyse the cell [26]. Thus, the coordination and
regulation of PG hydrolases is a critical process for the survival of
the bacterium.
Figure 6. Truncation causes RipATB to become active in M. smegmatis. (A) M. tuberculosis and M. smegmatis RipA were truncated to the active
endopeptidase domain (AD) and fused to the RipA secretion signal to generate RipATB-AD and RipASm-AD. Micrographs of M. smegmatis
overexpressing RipATB-AD or RipASm-AD were taken at 6 and 20 hours post induction with aTc. Membranes were visualized by FM4-64 staining. Scale
bar represents 2 mm. (B) M. smegmatis strains were constructed to overexpress full length RipATB and RipASm and truncated RipATB-AD, RipASm-AD
constructs under the control of aTc. Growth of these strains in the presence of inducer was assessed over time by OD600. These strains grown in the
absence of inducer as controls are shown in Figure S8.
doi:10.1371/journal.ppat.1003197.g006
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PLOS Pathogens | www.plospathogens.org 9 February 2013 | Volume 9 | Issue 2 | e1003197Figure 7. Processed RipA is toxic to M. tuberculosis. (A) Full length RipATB and truncated RipATB-AD was overexpressed in M. tuberculosis for
several days with addition of aTc. Cells were analyzed by microscopy for changes in morphology. Membranes were stained with FM4-64. Scale bar
represents 2 mM. (B) Growth of M. tuberculosis induced with aTc and overexpressing full length RipATB was measured by OD600. (C) Growth of M.
tuberculosis induced with aTc and overexpressing truncated RipATB-AD was measured by OD600. (D) M. tuberculosis RipA (RipATB) was overexpressed
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behave as an autolysin, resulting in the formation of spherical cells
and lysis when overexpressed or dysregulated. Overexpression of a
RipA dominant negative mutant not only causes loss of septal
resolution and chaining but also leads to uncontrolled activity of
endogenous PG hydrolases and lysis in a subset of cells. Thus,
RipA requires downstream interactions to govern its correct
function during septal resolution, as well as prevent lethal ectopic
hydrolase activity. The relatively low amount of dominant
negative RipA (about 10% of endogenous RipA) required for
chaining suggests that the cell has finely tuned the amount of
active RipA in the cell to near the level required for division; even
loss of 10% of these active RipA species (which is manifest in a
partial loss of endogenous RipA processing (Figure S6A) leads to a
block in septal resolution. While it is clear that RipASm C408A
overexpression can interfere with endogenous RipA activation,
given its known interactions with two other PG remodeling
enzymes that localize to the septum—RpfB and PBP1
[18,24,27]—it is possible the dominant negative mutant also
incorporates into and inhibits functional PG remodeling complex-
es. A combination of these two activities may contribute to the
RipASm C408A mutant’s potency at inducing chaining at
relatively low levels of induction.
Supporting the presence of regulatory RipA septal complexes,
we showed chemical inhibition of peptidoglycan incorporating
PBPs (of which the RipA binding partner PBP1 is a member)
results in cell rounding and lysis. Loss of PG synthetic activity
within a PG remodeling complex may allow cognate PG
hydrolases (such as RipA) to become hyperactive and lyse the
cell. We found that RipA depleted cells were specifically protected
against meropenem-induced killing, but remained sensitive to
other unrelated stresses. The depletion of the RipA likely affects
the expression of RipB, which resides downstream in the same
operon and has the same in vitro enzymatic specificity as RipA [14].
However, RipB is not essential for growth [28], and we have
previously shown that RipA appears to be more phenotypically
active than RipB in vivo. RipA, but not RipB, can complement the
growth inhibition and cell chaining defects observed in the ripAB
depletion strain [18]. While we cannot discount the possibility that
RipB contributes to meropenem-mediated killing, it seems more
likely that RipA is the main enzyme responsible for this lethal
phenotype. Together, our data suggests that meropenem-induced
killing is RipA dependent. However, we do observe a slight but
significant difference in growth between RipA depleted cells in the
presence and absence of meropenem (Figure 2C, lanes 2 and 4)
that suggests there may also be some RipA independent growth
inhibition (but not lysis) due to meropenem treatment. This may
reflect the fact that meropenem can target several transpeptidases
[21,22]. Despite this, since RipA appears to mediate meropenem’s
bactericidal capacity, and thus appears to be a more attractive
target for drug development, we would expect that a chemical
activator of RipA might act synergistically with meropenem
treatment. From these data alone, it may be possible that a RipA
inhibitor would be contraindicated in combination with merope-
nem, as it would antagonize the effect of PBP blockade, but we
have previously observed that RipA depletion can sensitize cells to
carbenicllin, a b-lactam antibiotic that also targets various
transpeptidases [18]. In previous assays, in contrast to merope-
nem, carbenicillin sensitization required long term RipA deple-
tion—it had no bactericidal effect on cells depleted for RipA in the
same time scale as our meropenem studies (Figure S1B). These
data suggest that extended treatment with a RipA inhibitor may
weaken cells enough to cause sensitivity to PBP inhibitors to which
the cell was previously resistant. It would be interesting to
determine whether RipA blockade can, in fact, synergize with
existing PG targeting antibiotics in vivo.
Because of the threat of lethal autolysin activity, cells can control
PG hydrolases through several, interconnected regulatory mech-
anisms. RipA is no exception, as we have found that in addition to
protein interactions that modulate its function, RipA requires
proteolytic activation. RipA exists primarily as smaller processed
forms in M. smegmatis. Recent work with RipA in vitro has mapped
a protease labile loop between a putative N terminal blocking
domain and the C terminal p60 PG hydrolase domain [25]. The
size of our truncated RipA species could contain the predicted size
of the p60 domain itself after cleavage within this loop, but we
were unable to determine the exact cleavage site(s) for RipA
proteolytic activation in vivo using site directed mutagenesis—
mutation of two pairs of highly scissile aspartate-proline peptide
bonds [29] at DP301 and DP315 to alanines had no effect on the
ability of RipA to be cleaved in M. smegmatis (Figure S5). This is
consistent with the activation of Auto amidase in Listeria
monocytogenes, which is also produced as a zymogen and becomes
active only after proteolytic processing and removal of an N
terminal inhibitory domain [30]. For Auto it was not possible to
isolate single amino acid substitutions that abolish processing;
instead, only deletion of the loop prevented proteolytic cleavage
[30], which suggests that the activation loop is intrinsically labile
and might be cleaved by many different proteases. Like Auto
amidase, RipA’s labile loop can be cleaved by many proteases in
vitro [25], and thus may be a target of several proteases in vivo. This
may explain why we see a smear of RipA truncated species in
wildtype mycobacteria, as opposed to a single truncated band.
Given the work of Ruggiero et al [25], it was likely that RipA is
produced as a zymogen in vivo, like Auto amindase. However,
another recent report suggested a different effect of the N terminal
domain in blocking RipA enzymatic activity [14,25]. While both
studies agreed that the N terminal domain appears to partially
block the C terminal endopeptidase active site, the authors
reached opposite conclusions as to whether the N terminus is
inhibitory. Ruggiero et al [25] found that truncated RipA
containing only the C terminal p60 domain was able to cleave
purified PG, while full length RipA had minimal activity [25]. In
contrast, Bo ¨th et al [14] showed that full length RipA was capable
of degrading small synthetic PG fragments, and truncation of the
N terminus produced no increase in enzymatic activity. However,
in the latter work, the authors did not perform enzymatic digests
using full length RipA on purified PG, as performed by Ruggiero
et al. It is possible that the reported differences between these
studies reflects the ability of small PG fragments to enter the RipA
active site, despite partial occlusion by the N terminal domain,
while access of larger substrates such as crosslinked and
polymerized PG is blocked. Our results favor the zymogen model,
as we have found that processing of the N terminal domain is
required for full RipA enzymatic activation in vivo. Likewise, the
lack of processing of RipATB in M. smegmatis likely accounts for the
in M. tuberculosis by induction (lane 2) with aTc for 48 hours. RipATB was then detected by anti-RipA Western blot analysis. Uninduced lysates were
used a control (lane 1). Full length RipA (arrow) and processed forms (brackets) were detected. (E) Total overexpressed protein was quantified from
(D) by performing densitometry analysis on bands apparent in the induced strain that are absent from the uninduced control. Fold change in total
RipATB overexpression relative to endogenous full length RipA signal was graphed.
doi:10.1371/journal.ppat.1003197.g007
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full length RipA could serve some degradation function on smaller
substrates in vivo, our results suggest that its main peptidoglycan
remodeling activity requires removal of the N terminus, which
contains a functional inhibitory domain.
Furthermore, using the less efficiently processed RipATB
homologue, we showed that protein interactions are not only
necessary for regulating functional septal complexes but also
promote RipA proteolytic activation. Full length RipASm is toxic
when overexpressed in M. smegmatis, but full length RipATB does
not produce the same phenotype. However, when we bypassed
processing and expressed the truncated RipATB active domain in
M. smegmatis, we observed a full gain of toxicity. These results
suggest that the interactions between RipASm and the cellular
factors necessary for processing do not occur with the RipATB
homologue. Since septation is a highly conserved process, these
data may not necessarily indicate different RipA binding partners
in slow and fast growing mycobacteria but rather that the M.
smegmatis and M. tuberculosis binding partners have evolved together
and may have higher affinities for one another.
Together, our work demonstrates that RipA regulation occurs
at multiple levels post-transcriptionally. We did not see any
transcriptional downregulation in cells transitioning into non-
replicating conditions (Figure S4). In fact, there was a significant
increase in RipA transcription during the transition to stationary
phase, but the functional consequence of this observation remains
unknown. Furthermore, while overexpression of the dominant
negative RipASm C408A allele modulates processing of endog-
enous RipA (Fig S6A), this is due to competition for processing
and not transcriptional feedback, even at high induction
conditions (Figure S6B). This lack of transcriptional modulation
is consistent with the observation that ripA expression has only
limited variation across dozens of published experimental
conditions (summarized on TBDB [31]), including general and
antibiotic stresses. The only conditions under which ripA
expression has been found to change are under non-replication
conditions and, recently, when cells are blocked in cell division
[32]. In the latter work, Plocinska et al found that ripA can be
regulated by the MtrAB two-component system. Specifically,
inhibiting septum formation prevents MtrB, which localizes at the
septum, from activating the MtrA response regulator, leading to
ripA downregulation. The authors proposed an interesting model
in which ripA transcription could be upregulated by MtrB when it
assembles at the division site; however, it remains unclear
whether MtrAB regulation of ripA transcription occurs during
normal growth or, instead, represents a stress response when cell
division is inhibited. While the question of ripA transcriptional
regulation during vegetative growth remains to be tested, our
work suggests that post-translational mechanisms like processing
may represent a key way of controlling RipA hydrolytic activity
during growth. Therefore, we propose that protein-protein
interactions help establish RipA function at the septum, where
it is then aided in becoming proteolytically cleaved in the
periplasm (Figure 8). After enzymatic activation, functional RipA
can rely on both upstream and downstream protein interactions
to help place it in the correct context during cell division—
inhibition of cognate PG synthases can lead to dysregulated cell
wall hydrolysis. The benefit of having multiple levels of RipA
regulation is that the cell can exert a tighter control over RipA’s
activation and potential autolysin activity.
Figure 8. Model for RipA activation through proteolytic processing and protein interactions. RipA is produced as a full length zymogen
with an N-terminal secretion signal. Once in the periplasm, RipA can bind to its interaction partners, leading to recruitment of proteases that cleave
the extended loop between an N-terminal blocking domain and the C-terminal peptidoglycan hydrolase domain. The cleaved RipA C-terminal
domain is now active and functions by cleaving the septal peptidoglycan, splitting the daughter cells, perhaps in conjunction with other hydrolases.
doi:10.1371/journal.ppat.1003197.g008
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activation than in M. smegmatis. The slow-growing mycobacteria
like M. tuberculosis and M. bovis BCG might well have slower rates
of PG hydrolysis and, consequently, reduced RipA activity.
Indeed, we find significant amounts of full length RipATB in
slow-growing mycobacterial lysates, a form that is not present in
M. smegmatis lysates. Furthermore, while expression of the active
domain of RipATB leads to severe growth inhibition with
concomitant bulging, overexpression of full length RipATB has
no such effect in M. tuberculosis, suggesting that slow-growing
mycobacteria proteolytically activate less RipA than their fast-
growing counterparts. The mechanism behind this additional
control over RipA activation is not known, but may be at the level
of expression or functional kinetics of the protease(s) responsible
for RipA cleavage. In fact, there is an additional stretch of amino
acids in RipASm compared to RipATB, which sits at the beginning
of the N terminal inhibitory domain (Figure S7). Ultimately, an
integrated mechanism for controlling PG hydrolases may repre-
sent a broad paradigm among cell wall degrading proteins.
Multiple levels of regulation might be required to synchronize
their activity to the cellular requirement while avoiding overac-
tivity and toxicity. In support of this, expression of a dominant
negative RipA allele at 10% of the endogenous RipA levels leads
to abnormal chaining. Thus, M. smegmatis appears to carefully
titrate the amount of processed RipA to nearly the minimum levels
it requires for division.
Finally, beyond division mechanics, post-translational PG
hydrolase regulation has the added benefit of inducing changes
quickly in response to changing environmental conditions,
especially in times of low transcription such as non-replicative
conditions [33,34]. The byproducts of PG hydrolysis can act as
sensors for the bacterial environment, whether in vitro or within a
host. For example, in B. subtilis, muropeptides have been found to
be sufficient to induce spore resuscitation [35,36] while in M.
tuberculosis, RpfB, a lysozyme that is known to be a RipA
interacting partner [27], is required for regrowth from both in
vitro and in vivo non-replication states [37,38]. The exact
mechanism behind mycobacterial resuscitation remains unclear,
but muropeptide-based signaling could play a major role. In fact,
we found processed RipA species in the culture filtrates and recent
work by Mir et al [39] demonstrated that the addition of
muropeptides to dormant M. tuberculosis facilitated resuscitation,
possibly through the binding and signaling of the essential
mycobacterial integral membrane kinase, PknB. Thus, soluble
PG remodeling proteins might play a role in fostering communi-
cation across a bacterial population.
In summary, this work has further defined two connected, but
distinct, mechanisms to regulate the activity of RipA, a potential
autolysin that is essential for septal resolution in mycobacteria.
The complexity of this regulation, which involves protein
interactions as well as proteolytic activation, underscores the
importance of carefully coordinating cell wall hydrolysis during
growth and division. By dissecting the molecular regulation of PG
hydrolases, we gain fundamental insight into how the bacterial cell
wall is dynamically maintained and also open up avenues for novel
chemotherapeutics, especially against major human pathogens
such as M. tuberculosis.
Materials and Methods
Strains and culture conditions
E. coli XL-1 Blue (Stratagene, Santa Clara, CA) were grown at
37uC in LB broth or agar and used for cloning. Selection was
performed using kanamycin (50 mg/mL), hygromycin (100 mg/
mL), ampcillin (100 mg/mL) or zeocin (25 mg/mL) when appro-
priate. Mycobacterium smegmatis mc
2155 was grown at 37uC, unless
otherwise indicated, in Middlebrook 7H9 broth supplemented
with ADC (bovine albumin fraction V (Sigma)(5 g/L)-dextrose
(2 g/L)-catalase (3 mg/L) and 0.05% Tween80. Selection of M.
smegmatis was achieved by supplementation of kanamycin (25 mg/
mL), hygromycin (50 mg/mL) or zeocin (25 mg/mL). M. tuberculosis
H37Rv and M. bovis BCG were grown in liquid Middlebrook 7H9
broth and plated on Middlebrook 7H10 agar supplemented with
OADC (oleic acid-albumin-dextrose-catalase) (BD Biosciences,
Franklin Lakes, NJ). M. smegmatis in which the RipA endogenous
promoter has been replaced by a tetracycline inducible promoter
was previously constructed and characterized in [18].
Recombinant DNA constructs
Mtb RipA (Rv1477) and Msmeg RipA (MSMEG_3145)
mutants were constructed through PCR stitching using the
following primers:
Mtb C383A RipA Forward (CCGTCGGCTTCGACGCCT-
CAGGCCTGGTGTTG)
Mtb C383A Reverse (CAACACCAGGCCTGAGGCGTC-
GAAGCCGACGG)
Msmeg RipA C408A Forward (ACCGTCGGCTTCGAC-
gcCTCGGGTCTGATG)
Msmeg C408A Reverse (CATCAGACCCGAGgcGTCGAAG-
CCGACGGT).
Msmeg RipA DP301AA DP315AA double point mutants were
constructed by PCR stitching using the following primers:
Msmeg RipA DP315AA Forward (GCGATCCCGAGCGCG-
TTCGTCAGCGGTGcCgCCATCGCGATCATCAAC)
Msmeg RipA DP300AA Reverse (GAACGCGCTCGGGA-
TCGCAGGCAGGGTCgCGgCCCACACGGCCCAGTT)
Secreted, RipA catalytic domain constructs were made using
the M. smegmatis RipA secretion signal amino acids 1–51—Reverse
primer: GAACCTgatatcGACGAGCGTGGCGAG. The RipATB
active domain contained amino acids 332–472, while RipASm
active domain contained amino acids 357 to 494.
Tetracycline inducible strains were created by cloning RipA
genes into the Tet On plasmid, pSE100. For time-lapse
microscopy, green fluorescent protein (GFP) was cloned down-
stream of RipASm C408A to create a transcriptional reporter. GFP
was also cloned downstream in frame with RipASm to create a
translational fusion. These inducible plasmids were then trans-
formed into M. smegmatis in which the plasmid pMC1s, which
encodes the tetR gene, had already been integrated at the L5 site.
Protein expression
Recombinant gene products were expressed using a published
anhydrotetracycline inducible system [40]. Anhydrotetracycline
induction was performed with 100 ng/mL of anhydrotetracycline
unless otherwise indicated.
Meropenem treatment and CFU enumeration
M. smegmatis with chromosomal ripA under the control of a
tetracycline inducible promoter was grown in 7H9 ADC in the
presence of 100 ng/mL anhydrotetracycline (aTc) to an OD of
0.2. The culture was split, the cells pelleted at 5000 rpm for
10 minutes and resuspended in 7H9 ADC with (RipA replete) or
without (RipA depleted) aTc for 6 hours. Once depletion in the no
inducer culture was confirmed by microscopic examination of the
culture for chaining, 10 mg/mL meropenem were added and the
cultures and cells grown at 37uC for 6 hours. After 6 hours of
meropenem treatment, both RipA replete and depleted cultures
were serially diluted and plated onto LB supplemented with
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incubated for 3 days at 37uC and colonies were counted. As a
control, RipA replete and depleted cells were also treated with
0.08% SDS (w/vol), 0.08 mg/mL streptomycin (Sigma) or
500 mg/mL carbenicillin (Sigma).
Protein fractionation and preparation
M. smegmatis cells were grown overnight in 7H9 supplemented
with dextrose (2 g/L), but not albumin or catalase at 37uC until
mid log phase. This media should be made fresh for every
experiment. Cells were pelleted and culture supernatants were
precipitated with 10% TCA (tricholoroacetic acid) overnight at
4uC. Precipitates were pelleted at 15,0006g for 15 minutes at 4uC
and washed once with ice cold acetone. The acetone wash was
decanted, and the pellet was air dried at room temperature.
Precipitated protein was resuspended in reducing SDS loading
buffer at 65uC, for 10 minutes.
M. smegmatis cells was fractionated by French press three times.
Unbroken cells and insoluble material were pelleted at 10006g for
10 minutes. The supernatant was collected and insoluble cell wall
material pelleted at 27,0006ga t4 uC for 40 minutes. The
remaining supernatant was centrifuged at 100,0006g for 1 hour
at 4uC to pellet the membrane fraction, while te supernatant
contains the soluble cytosolic fraction.
Immunoblotting and densitometry analyses
Rabbit polyclonal antibody was made from an affinity purified
using a peptide derived from the Msmeg RipA epitope:
NAGRKIPSSQMRRG (Genscript, Piscataway, NJ). Anti-RipA
antibody was diluted to 1 mg/mL and used at a dilution of 1:1000.
Anti-FLAG antibody (Sigma, St. Louis, MO) was used according
to manufacturer’s instructions. Protein samples were mixed with
4x Laemmli SDS PAGE buffer (Boston BioProducts, Inc, Boston
MA) and boiled for 5 minutes. M. bovis BCG and M. tuberculosis
protein samples were boiled for 20 minutes. Proteins were
separated on 12% Tris-glycine polyacrylamide gels, transferred
to PVDF membrane (Pall Corp, Pensacola, FL), probed with anti-
sera and developed with SuperSignal chemiluminescent reagent
(Thermo, Pittsburg, PA). Densitometry on Western blot signal was
performed using Multiguage software (Fujifilm).
Microscopy and imaging
For TMA-DPH (Invitrogen, Carlsbad, CA) staining, bacteria
were centrifuged and media removed. Cell pellets were resus-
pended in 50 mM TMA-DPH in PBS and incubated in the dark
for 10 minutes. Cells were also stained in FM4-64Fx (Invitrogen)
at a concentration of 5 mg/mL in PBS for 10 minutes, and then
fixed and stored in 4% paraformaldehyde. Samples were imaged
using a Nikon TE-200E microscope with a 100x (NA1.4) objective
and captured with an Orca-II ER cooled CCD camera
(Hamamatsu, Japan). Shutter and image acquisition were
controlled using Metamorph Software (Molecular Devices). Final
images were prepared using Adobe Photoshop 7.0.
Time lapse microscopy
Four Gene Frames (Fisher Scientific) were stacked onto a glass
slide and filled with Middlebrook 7H9 in low melting point agar,
supplemented with 50 mg/mL of hygromycin and 100 ng/mL
aTc. A glass coverslip was flattened atop the agar to create a
smooth surface and then removed after the agar set. The agar pad
was sliced into eighths and seven of the pieces were removed to
provide an air reservoir. Onto the remaining pad, exponential
phase M. smegmatis was pipetted and allowed to adsorb until the
surface of the pad appeared dry. Finally, a glass coverslip was
applied and the slide was imaged on the microscope in an
environmental chamber warmed to 37uC (Applied Precision, Inc.).
Time-lapse images were acquired using a DeltaVision epifluor-
escence microscope with an automated stage enclosed with a 100x
oil objective (Plan APO NA1.40). Cells were imaged every
10 minutes for up to 18 hours using brightfield and fluorescence
illumination (461–489 nm; Applied Precision, Inc.) and images
recorded with a CoolSnap HQ2 camera (Photometric). Focus was
maintained using the software-based autofocus (Applied Precision,
Inc).
Real time PCR
M. smegmatis samples were collected at the indicated growth
phases (log, OD600=0.5; early stationary, OD600=2; Stationary,
24 hours of OD600.7) and stored in RNA Protect Bacteria
Reagent (Qiagen, Valencia, CA) at 280uC. The pellets were then
mechanically disrupted by beadbeatting for three 1-minute cycles,
and RNA isolated using the RNeasy Mini Kit (Qiagen), with one
additional DNAse treatment (Qiagen) on the column before
elution and a second DNAse digestion with Turbo DNase
according to manufacturer’s instructions (Ambion, Foster City,
CA). Reverse transcription was carried out using the High
Capacity cDNA Reverse Transcription kit (Applied Biosystem,
Foster City, CA). Quantitative PCR reactions were set up in
Power SyBr green PCR master mix (Applied Biosystems) and run
and analyzed on a Step One Plus real time system (Applied
Biosystems).
ripA expression was measured using the following intragenic
primers: 59 CAGATCGGTGTGCCCTACTC; 59 GGCGAA-
CATGTAGAGCATCAG; or against the 39 UTR region: 59
GCTCGAGGCCCCTTACAC; 59 GGAGCGCAAAGTAAT-
CCCATCAG
ripA expression was normalized to sigA levels, which utilized the
following primers: 59 AAGACACCGACCTGGAACTC; 59AG-
CTTCTTCTTCCTCGTCCTC.
Supporting Information
Figure S1 RipA depleted cells are not more resistant to
general stress. (A) The M. smegmatis RipA conditional depletion
strain was grown in the presence or absence of inducer for 6 hours,
after which, cells were confirmed to be depleted for RipA by
microscopic visualization of short chains in the absence of inducer
(red arrows). Membranes were visualized by FM4-64. Scale bar
represents 2 mm. (B) RipA replete or pre-depleted cells were
treated for an additional 6 hours with either 0.8 mg/mL
streptomycin (Sm), 0.08% SDS or 500 mg/mL carbenicillin (Cb).
After treatment, cells were serially diluted and plated for CFU.
*=the difference between RipA replete and depleted growth or
survival is significant with p-value of , 0.1. ns=p-value is not
significant (.0.1).
(TIF)
Figure S2 RipA depleted cells are not morphologically
resistant to general stress. RipA replete and pre-depleted M.
smegmatis were treated with various chemical stresses (0.8 mg/mL
streptomycin, 0.08% SDS or 500 mg/mL carbenicillin for 6 hours,
stained with FM4-64 and morphology assessed by fluorescent
microscopy. Scale bar represents 2 mm.
(TIF)
Figure S3 RipA is not post-transcriptionally downregu-
lated. Quantitative PCR was performed against the ripA
transcript during different growth phases of wildtype M. smegmatis.
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values: ns, non significant; *, p , 0.05.
(TIF)
Figure S4 RipA processing is within the cell wall
compartment. (A) Anti-RipA Western blot of fractionated
wildtype M. smegmatis (lanes 2), cells depleted for RipA (lanes 1) or
cells overexpressing inactive RipASm C408A (lanes 3). (B) Anti-
RpoB Western blot of fractionated wildtype (lanes 1), RipA
depleted (lanes 2) or RipASm C408A overexpressing (lanes 3) M.
smegmatis. (C) Anti-Ag85 Western blot of fractionated wildtype
(lanes 1), RipA depleted (lanes 2) or RipASm C408A overexpress-
ing (lanes 3) M. smegmatis. Each lane was standardized to total
protein from the cell wall fraction. Due to the heavy presence of
recombinant RipA in RipASm C408A induced cells, upon protein
normalization, there is an enrichment for RipA protein, which
leads to an apparent decrease in other cell wall proteins, such as
Ag85.
(TIF)
Figure S5 DP301 and DP315 residues are not necessary
for RipA cleavage. Site-directed mutagenesis was used to create
a RipASm DP300AA DP315AA double substitution mutant in the
RipASm C408A background. This mutant (DP300AA DP315AA
C408A) was fused to a FLAG tag and expression induced with aTc
in M. smegmatis. Total cell lysate was run on SDS-PAGE and RipA
processing was monitored by Western blot analysis using an anti-
FLAG antibody. RipA processed species are indicated in brackets
and RipA full length is indicated by an arrow.
(TIF)
Figure S6 Overexpression of RipASm C408A is mild
relative to endogenous RipA levels. (A) The M. smegmatis
RipASm C408A overexpression strain was grown under various
inducer concentrations and total protein harvested for Western
blot analysis with anti-RipA antibody (top panel) and anti-ClpP
antibody (loading control, bottom panel). Full length recombinant
(arrow) and processed RipA C408A was detected (bottom
brackets), as well as endogenous RipA (upper brackets). (B) Total
RNA was harvested from cells grown in various concentrations of
inducer and quantitative RT-PCR performed against endogenous
RipA (primers detect the ripA 39 UTR region) and normalized to
sigA levels. ‘ns’=not significant (p-value.0.1).
(TIF)
Figure S7 Alignments between RipA homologues from
M. tuberculosis and M. smegmatis. (A) Amino acid
alignment between RipA-TB from M. tuberculosis and RipA-smeg
from M. smegmatis. Conserved residues are shown in black or
denoted with ‘ * ’ in the consensus row, while shared amino acids
with similar properties are in gray or marked with a ‘.’i nt h e
consensus line. (B) Schematic diagram of the predicted domain
structure of RipATB and RipASm from M. tuberculosis and M.
smegmatis, respectively. Both proteins have an N terminal secretion
signal (black), a DUF or domain of unknown function (blue), an
inhibitory domain (red), an extended loop (black line) and an
NLPC/p60 family peptidoglycan hydrolysis domain (orange).
RipASm also has an additional 33 amino acid extension at the
junction between the DUF and inhibitory domains (green box).
(TIF)
Figure S8 Uninduced strains of M. smegmatis were
equally viable. M. smegmatis strains were constructed to
overexpress full length RipATB and RipASm and truncated
RipATB-AD, RipASm-AD constructs under the control of aTc.
As negative controls, growth of these strains in the absence of
inducer was assessed over time by OD600.
(TIF)
Figure S9 RipA processing is rate limiting in slow
growing mycobacteria. (A) Full length RipASm was overex-
pressed in M. bovis BCG for 48 hours. Cells were analyzed for
changes in morphology by microscopy. Membranes were stained
with FM4-64. Scale bar represents 2 mm. (B) Anti-RipA Western
blot of M. bovis BCG induced to overexpress RipASm (lane 2).
Uninduced M. bovis BCG lysate was run as a control (lane 1). Full
length RipA (arrow), as well as processed forms (brackets), were
detected.
(TIF)
Video S1 RipASm overexpressed cells lyse. M. smegmatis
carrying a plasmid in which wildtype RipASm was fused to GFP
was grown on an agar pad with the inducer aTc, in order to
overexpress wild-type RipA. Micrographs of the GFP signal were
captured every 10 minutes by fluorescence microscopy and a time-
lapse movie was compiled from the individual timepoints. Lysis of
RipA expressing cells can be identified by loss of GFP between
time points.
(AVI)
Video S2 RipASm C408A cells predominantly chain but
also occasionally lyse. M. smegmatis were grown on an agar
pad, containing the inducer aTc in order to overexpress the
catalytic mutant of RipASm (C408A). A cytosolic GFP reporter was
used to identify cells inducing RipASm C408A expression and
visualize chains of cells. Images were captured every 10 minutes,
and a time-lapse movie was generated. Lysis of specific cells within
the chain can be observed by localized loss of GFP signal between
frames.
(AVI)
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